- Home
- NYMTL vs OCEAW Comparison
NYMTL vs OCEAW Comparison
Compare NYMTL & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMTL
- OCEAW
- Stock Information
- Founded
- NYMTL N/A
- OCEAW N/A
- Country
- NYMTL United States
- OCEAW United States
- Employees
- NYMTL 79
- OCEAW 7
- Industry
- NYMTL Real Estate Investment Trusts
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- NYMTL Real Estate
- OCEAW Health Care
- Exchange
- NYMTL Nasdaq
- OCEAW Nasdaq
- Market Cap
- NYMTL N/A
- OCEAW N/A
- IPO Year
- NYMTL N/A
- OCEAW 2021
- Fundamental
- Price
- NYMTL $21.80
- OCEAW $0.03
- Analyst Decision
- NYMTL
- OCEAW
- Analyst Count
- NYMTL 0
- OCEAW 0
- Target Price
- NYMTL N/A
- OCEAW N/A
- AVG Volume (30 Days)
- NYMTL N/A
- OCEAW N/A
- Earning Date
- NYMTL N/A
- OCEAW N/A
- Dividend Yield
- NYMTL N/A
- OCEAW N/A
- EPS Growth
- NYMTL N/A
- OCEAW N/A
- EPS
- NYMTL N/A
- OCEAW N/A
- Revenue
- NYMTL N/A
- OCEAW N/A
- Revenue This Year
- NYMTL N/A
- OCEAW N/A
- Revenue Next Year
- NYMTL N/A
- OCEAW N/A
- P/E Ratio
- NYMTL N/A
- OCEAW N/A
- Revenue Growth
- NYMTL N/A
- OCEAW N/A
- 52 Week Low
- NYMTL N/A
- OCEAW N/A
- 52 Week High
- NYMTL N/A
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- NYMTL 41.28
- OCEAW N/A
- Support Level
- NYMTL $21.97
- OCEAW N/A
- Resistance Level
- NYMTL $22.30
- OCEAW N/A
- Average True Range (ATR)
- NYMTL 0.25
- OCEAW 0.00
- MACD
- NYMTL -0.03
- OCEAW 0.00
- Stochastic Oscillator
- NYMTL 29.41
- OCEAW 0.00
About NYMTL New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.